Eczema

9 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Eczema
Treatment and conditionWhere it standsTrials
Abrocitinib for eczemaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amlitelimab for eczemaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ATI-045 for eczemaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dupilumab for eczemaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)7
Lebrikizumab for eczemaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Optical Coherence Tomography + Reflectance confocal microscopy + DUPILUMAB for eczemaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for eczemaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Placebo + DUPILUMAB for eczemaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + LEBRIKIZUMAB for eczemaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1